glp-1 and gastric emptying Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release are used to treat type 2 diabetes mellitus and #obesity. receptor agonists and GLP-1 and glucose-dependent insulinotropic Quantified Metrics of Gastric Emptying

It is worth noting that, besides the weight loss leaders, Eli Lilly and Novo Nordisk, other companies planning to enter the weight loss space are prioritizing small molecule GLP-1 drugs, as seen in the partnership between Chengyi Biotech and AstraZeneca

Kurbanoglu, S., Ozkan, S

Start with gentle exercise such as short walks, gradually increasing duration and intensity as tolerated

Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, Periera BG, Feldman HI, Kusek JW, Joffe MM, Raj DS

Wu L, Wang K, Wang W, Wen Z, Wang P, Liu L, Wang DW

doi: 10.1126/sciadv.adf3566